🇺🇸 FDA
Pipeline program

MDNA11

MDNA11-01

Phase 2 small_molecule active

Quick answer

MDNA11 for Advanced Solid Tumor is a Phase 2 program (small_molecule) at Medicenna Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Medicenna Therapeutics
Indication
Advanced Solid Tumor
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials